NAD+
In stockβ-NADNicotinamide adenine dinucleotide, a coenzyme found in all living cells. It is a dinucleotide, not a peptide. Researchers study it as the redox carrier and as a cosubstrate for sirtuins, CD38 and PARP enzymes.
Supplied as a single-chamber lyophilized vial with a colour-coded cap (Longevity & Energy).
Research literature, not dosing or treatment instructions.
- NAD+ is a coenzyme for redox reactions and an essential cofactor for non-redox NAD+-dependent enzymes including sirtuins, CD38 and poly(ADP-ribose) polymerases. (PMID 33353981, PMID 26785480)
- Reviews describe NAD+ homeostasis, its biosynthesis pathways and the link between energy metabolism, mitochondria and the nucleus. (PMID 32694684, PMID 26118927)
Add the solvent slowly along the vial wall; swirl gently, never shake. Allow to dissolve fully. Six-step guide with photos →
Concentration calculator only. Enter the mass being calculated; blend components are not added automatically. Products are for in-vitro research.
Refer to the product label and supplier documentation for storage conditions. Lot-specific storage and expiry information is not available here.
Each certificate is published with its lot number.
Questions about NAD+
How much published research is there on NAD+?
The research library's PubMed search for NAD+ returned 1,232 records on 5 October 2026, 270 of them reviews. The library lists 4 studies chosen for what they measured.
Is NAD+ an approved medicine?
No centrally authorised medicine containing NAD+ is listed in the EMA medicines database (checked 5 October 2026), and the research material we supply is not a medicine. It is supplied for in-vitro laboratory research only, not for human or veterinary use.
Is NAD+ a peptide?
No. NAD+ is a dinucleotide coenzyme, nicotinamide adenine dinucleotide. It is listed in the same catalog as the peptides and carries the same lot and certificate rules, and its tile is marked as a non-peptide.
How is the identity of NAD+ confirmed on a certificate?
A research-grade certificate of analysis typically reports identity by mass spectrometry and purity by HPLC. The mass result is read against the average molecular weight of 663.4 g/mol listed on this page. The research library's guide to reading a certificate explains each field.
What other names is NAD+ published under?
NAD+ is also written β-NAD and Nicotinamide adenine dinucleotide. The catalog lists it under the name NAD+.
Is this product for human use?
No. Peptency products are supplied for in-vitro research only. Not for human or veterinary use, not for diagnosis or therapy.
Where can I find shipping information?
Current shipping rates and delivery information are on the Shipping & payment page, and the rates that apply to your order are shown at checkout.
Often studied with
For research use only. Not for human or veterinary use.
What is NAD+?
NAD+ is nicotinamide adenine dinucleotide, a coenzyme found in all living cells. It carries electrons in reduction-oxidation reactions and is a cosubstrate for sirtuins, CD38 and poly(ADP-ribose) polymerases. It is not a peptide, and it is listed in the catalog as a research material for laboratory use only. We supply NAD+ as a lyophilized vial for in-vitro laboratory research only.
What are the chemical identifiers of NAD+?
NAD+ has the molecular formula C21H27N7O14P2, an average molecular weight of 663.4 g/mol and CAS number 53-84-9.
Chemistry checked against PubChem (CID 5892), 5 October 2026; full chemistry record in the research library.
What does published research on NAD+ cover?
A PubMed search for NAD+ returned 1,232 records on 5 October 2026, 270 of them reviews. Our research library lists 4 of these studies, chosen for what they measured.
- NAD+ is a coenzyme for redox reactions and an essential cofactor for non-redox NAD+-dependent enzymes including sirtuins, CD38 and poly(ADP-ribose) polymerases. (Covarrubias et al., Nat Rev Mol Cell Biol, 2021; PMID 33353981; Verdin, Science, 2015; PMID 26785480)
- Reviews describe NAD+ homeostasis, its biosynthesis pathways and the link between energy metabolism, mitochondria and the nucleus. (Katsyuba et al., Nat Metab, 2020; PMID 32694684; Cantó et al., Cell Metab, 2015; PMID 26118927)
Mechanism, every cited study and the regulator records are on the NAD+ page of the research library. Papers are listed by what they measured, not as evidence of any use.
How is NAD+ supplied and stored?
NAD+ is supplied as a lyophilized (freeze-dried) powder in a sealed vial, for in-vitro laboratory research only. Our stated storage condition for the sealed lyophilized vial is 2 to 8 °C. The label and the lot certificate carry the lot-specific storage condition and expiry date.
What is the regulatory status of NAD+?
The EMA medicines database (checked 5 October 2026) lists no centrally authorised medicine naming NAD+ (searched as nadide or nicotinamide adenine dinucleotide) as an active substance. National authorisations are not in that dataset.
No SmPC, PIL or PAR document in MHRA Products matches the exact name (checked 5 October 2026).
A regulator record is information about a database entry. It is not advice and not a statement that any use is lawful or unlawful in any country. How regulators approach research peptides.
Which related research pages and compounds are listed?
- NAD+: chemistry, literature and regulatory status
- NAD+ metabolism and NNMT
- How to read a certificate of analysis
Related compounds in the catalog: